# Recombinant RSV pre-fusion F protein (RSVPreF3)

## Arexvy RSV Vaccine 0.5mL/dose

| TAH Drug Code      | [IAREX](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IAREX)                                                                                                                                                                                                                                                          |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Respiratory syncytial virus–associated lower respiratory tract disease prevention: Active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in persons >60 years of age and persons 50 to 59 years of age who are at increased risk for LRTD caused by RSV. |
| Dosing             | IM: 0.5 mL as a single dose.                                                                                                                                                                                                                                                                                                    |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Severe hypersensitivity (eg， anaphylaxis) to respiratory syncytial virus vaccine or any component of the formulation.                                                                                                                                                                                                          |
| Adverse Effects    | >10%: Local: Erythema at injection site (8% to 13%)， pain at injection site (61% to 76%) Nervous system: Fatigue (34% to 40%)， headache (27% to 32%) Neuromuscular & skeletal: Arthralgia (18% to 23%)， myalgia (29% to 36%) 1% to 10%: Local: Swelling at injection site (6% to 10%) Miscellaneous: Fever (2% to 3%)        |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                         |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/recombinant-rsv-pre-fusion-f-protein-(rsvpref3)-drug-information)                                                                                                                                                                                                                  |

